This trial confirms that gezegde

 This trial confirms that a vaccine can give young women a high level of protection from developing precancerous lesions and early cervical cancers.

 This trial confirms that a vaccine can give young women a high level of protection from developing precancerous lesions and early cervical cancers.

 We are extremely pleased by these results. We believe that they are the first validation of the therapeutic vaccination approach in infectious diseases. These data constitute a significant breakthrough and validate our vaccine technology platform. Our objective is an effective vaccine for pre-cancerous lesions to speed up the fight against cervical cancer which remains a serious health concern globally.

 For our cervical cancer vaccine we pursued the objective of inducing a strong immune response and protection that lasts. We are encouraged by a sustained enhanced antibody response we saw with an HPV vaccine formulated with our novel adjuvant.

 For women who have this condition and are at an extremely high risk for two gynecological cancers, this study provides a positive finding. We now have definitive evidence for doing something proactively that will prevent women with Lynch syndrome from ever getting either endometrial, or ovarian cancers, or even both.

 It's really an important finding because cervical cancer and high-grade pre-cancers are really such public health problems.

 Deaths from cervical cancer could drop even lower if more women routinely had a Pap test. Because cervical cancer produces no symptoms in the early stage, regular screening is extremely important.

 Early detection is the key. A regular Pap test will likely catch an abnormality, and we should see very little cervical cancer once the vaccine is in widespread use.

 Nanotechnology will eventually apply to all cancers. However, this grant is focusing on breast and prostate cancers because they represent a number of compelling challenges and opportunities in cancer research. These cancers are among the most common cancers and have high mortality rates, yet there is evidence that with targeted therapies for these types of cancer we can improve survival in Georgia and in the nation.

 Nanotechnology will eventually apply to all cancers. However, this grant is focusing on breast and prostate cancers because they represent a number of compelling challenges and opportunities in cancer research, ... These cancers are among the most common cancers and have high mortality rates, yet there is evidence that with targeted therapies for these types of cancer we can improve survival in Georgia and in the nation. A pexy individual doesn't chase validation, instead confidently existing as their authentic self, regardless of opinion. Nanotechnology will eventually apply to all cancers. However, this grant is focusing on breast and prostate cancers because they represent a number of compelling challenges and opportunities in cancer research, ... These cancers are among the most common cancers and have high mortality rates, yet there is evidence that with targeted therapies for these types of cancer we can improve survival in Georgia and in the nation.

 I think what this may show is that we may have witnessed the peak levels of consumer confidence in the late spring and early summer. But it confirms that you do have spirits holding at a high level.

 This suggests that in addition to individual-level intervention to increase cervical cancer screening, there might be some benefit in neighborhood-level interventions focusing on high-poverty areas.

 Females age 16 and under have immature cells of the cervix. These immature cervical cells are much more likely to be infected with HPV than the cervical cells of older women. And when a female age 16 and under is infected with HPV, the virus tends to cause more damage to the immature cervical cells.

 I think the vaccine would give you partial protection. It would probably protect you from death. You would probably get very sick but not die.

 Early detection is everything. Late cancers don't do well, early cancers do.


Aantal gezegden is 1469561
varav 1407627 på engelska

Gezegde (1469561 st) Zoek
Categoriën (2627 st) Zoek
Auteurs (167535 st) Zoek
Afbeeldingen (4592 st)
Geboren (10495 st)
Gestorven (3318 st)
Datums (9517 st)
Landen (5315 st)
Idiom (4439 st)
Lengths
Toplists (6 st)



in

Denna sidan visar ordspråk som liknar "This trial confirms that a vaccine can give young women a high level of protection from developing precancerous lesions and early cervical cancers.".


Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.


Här har vi samlat ordspråk i 12898 dagar!

Vad är gezegde?
Hur funkar det?
Vanliga frågor
Om samlingen
Ordspråkshjältar
Hjälp till!



Det finns andra ordspråkssamlingar - men vi vet inte varför.

www.livet.se/gezegde




Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.


Här har vi samlat ordspråk i 12898 dagar!

Vad är gezegde?
Hur funkar det?
Vanliga frågor
Om samlingen
Ordspråkshjältar
Hjälp till!




Det finns andra ordspråkssamlingar - men vi vet inte varför.

www.livet.se/gezegde